Elevance Health (A58) Stock Overview

Operates as a health benefits company in the United States. More details

A58 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	2/6
Past Performance	2/6
Financial Health	5/6
Dividends	5/6

Rewards

Trading at 75.9% below our estimate of its fair value

Earnings are forecast to grow 11.52% per year

Pays a reliable dividend of 1.95%

Risk Analysis

Shares are highly illiquid

A58 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Elevance Health, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Elevance Health
Historical stock prices
Current Share Price	US$301.90
52 Week High	US$301.90
52 Week Low	US$257.90
Beta	0.59
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-37.08%
5 Year Change	n/a
Change since IPO	403.25%

Recent updates

Shareholder Returns

	A58	DE Healthcare	DE Market
7D	11.1%	2.5%	2.7%
1Y	n/a	30.1%	14.6%

Return vs Industry: Insufficient data to determine how A58 performed against the German Healthcare industry.

Return vs Market: Insufficient data to determine how A58 performed against the German Market.

Price Volatility

Is A58's price volatile compared to industry and market?
A58 volatility
A58 Average Weekly Movement	n/a
Healthcare Industry Average Movement	5.5%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	12.3%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: A58's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine A58's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2001	104,200	Gail Boudreaux	www.elevancehealth.com

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits.

Elevance Health, Inc. Fundamentals Summary

How do Elevance Health's earnings and revenue compare to its market cap?
A58 fundamental statistics
Market cap	€67.23b
Earnings (TTM)	€4.57b
Revenue (TTM)	€161.21b

14.7x

P/E Ratio

0.4x

P/S Ratio

Is A58 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A58 income statement (TTM)
Revenue	US$189.25b
Cost of Revenue	US$138.47b
Gross Profit	US$50.79b
Other Expenses	US$45.43b
Earnings	US$5.36b

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Oct 21, 2025

Earnings per share (EPS)	23.80
Gross Margin	26.84%
Net Profit Margin	2.83%
Debt/Equity Ratio	68.8%

How did A58 perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

28%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/05 20:52
End of Day Share Price	2025/10/03 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Elevance Health, Inc. is covered by 49 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jasper Hellweg	Argus Research Company
Hua Ha	Baird
Ishan Majumdar	Baptista Research

Elevance Health, Inc.XTRA:A58 Stock Report